Diabetic Macular Edema

Study finds age impacts effectiveness of anti-VEGF treatments for diabetic macular edema

Researchers have found that older patients experience weaker responses to anti-VEGF treatments for diabetic macular edema (DME) compared to younger patients, according to a poster presented at ASRS 2024. The study combined data from 4 major clinical trials to explore how age affects treatment outcomes in terms of visual acuity...